Clinical Trials Logo

Clinical Trial Summary

Bone and joint infections (BJI) are most often bacterial infections that can occur after surgery or de novo. They are rarely fatal in the short term, but are associated with significant morbidity, impaired quality of life and significant costs. Treatment of BJI is based on antibiotic therapy, often combined with surgery. Antibiotic therapy, at high doses, lasts a minimum of 6 weeks. It can be responsible for severe adverse effects. These characteristics (prolonged duration, multiple daily doses, and adverse effects) are known to negatively affect treatment adherence in general.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Drug-Related Side Effects and Adverse Reactions
  • Treatment Adherence and Compliance

NCT number NCT05202964
Study type Observational
Source Hospices Civils de Lyon
Contact Tristan FERRY, MD, PHD
Phone 4 26 73 29 38
Email [email protected]
Status Recruiting
Phase
Start date February 2022
Completion date May 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03258151 - Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
Recruiting NCT04597593 - Association Between Genetic Variant Scores and DOACs (DARES2)
Recruiting NCT05096338 - Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
Completed NCT02457039 - Acupuncture Prevents Chemobrain in Breast Cancer Patients N/A
Completed NCT02779530 - CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs Phase 4
Not yet recruiting NCT04077281 - Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions N/A
Recruiting NCT03047863 - Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors N/A
Recruiting NCT03051880 - Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors N/A
Completed NCT02482025 - The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial N/A
Not yet recruiting NCT03147157 - The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation N/A
Recruiting NCT03156348 - Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults N/A
Recruiting NCT03501108 - Discontinuation of Long-term Medications in Older People Entering Nursing Home Care N/A
Completed NCT03227653 - Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
Completed NCT03177174 - Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma N/A
Not yet recruiting NCT05247814 - Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients
Recruiting NCT03938597 - Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
Recruiting NCT05078190 - Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
Active, not recruiting NCT02119078 - Acute Care for Elders (ACE) Program at OHSU Hospital N/A
Terminated NCT04247919 - DOAC ADRs Retrospective Study
Recruiting NCT04617340 - Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE N/A